Publikationen in Zusammenarbeit mit Forschern von Fundación Jiménez Díaz (1)

2022

  1. MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study

    European Journal of Cancer, Vol. 174, pp. S122